Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 21, 2018
Pharmacy Choice - Pharmaceutical News - Pfizer Announces FDA Approval Of LYRICA CR Extended-release Tablets CV - March 21, 2018

Pharmacy News Article

 10/12/17 - Pfizer Announces FDA Approval Of LYRICA CR Extended-release Tablets CV

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the U.S. FDA has approved LYRICA CR (pregabalin) extended-release tablets CV as once-daily therapy for the management of neuropathic pain associated with diabetic peripheral neuropathy and the management of postherpetic neuralgia. LYRICA CR did not receive approval for the management of fibromyalgia.

The efficacy and safety of LYRICA CR in postherpetic neuralgia was established in a randomized placebo-controlled clinical trial conducted in a total of 801 patients with postherpetic neuralgia who entered single-blind treatment with LYRICA CR.

Copyright RTT News/dpa-AFX

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Mar 21: HIV Medications: Newer Drugs, Newer Guidelines
Last Chance
Mar 22: Treatment of Parkinson's Disease and Comorbid Conditions
Mar 25: Alternatives and Complements to Prescription Pain Management
Mar 26: Management of Alcohol Use Disorders
Mar 27: Pharmacy & the Opioid Crisis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement